Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Beneficial effects of warfarin in patients with cardiac disorders

March 24, 1998

Merck & Co. reveals new prodrugs of fibrinogen receptor antagonists

March 23, 1998

Antiplatelet agents reported by researchers at Nippon Steel

March 20, 1998

Modified factor VII interrupts the coagulation cascade

March 18, 1998

Novartis describes new thrombin inhibitors

March 17, 1998

Centocor completes acquisition of reteplase

March 16, 1998

Improved anticoagulants in development at Gyogyszerkutato Intezet

March 16, 1998

Treatment of acute coronary syndromes by thrombin inhibition

March 16, 1998

Boehringer Ingelheim discloses new antiplatelet agents

March 13, 1998

Antithrombotics developed at Warner-Lambert

March 12, 1998

Popular Stories

University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Beijing Innocare Pharma Tech discloses new GSPT1 degradation inducers
BioWorld Science
Beijing Innocare Pharma Tech Co. Ltd. has synthesized new antibody-drug conjugates comprising antibody or antigen-binding fragment covalently linked to eukaryotic...